Estimation of male gonorrhoea incidence, in France, in 1991. NLM AIDSLINE Important note: Information in this article was accurate in 1993. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Estimation of male gonorrhoea incidence, in France, in 1991.

Int Conf AIDS. 1993 Jun 6-11;9(1):103 (abstract no. WS-C22-1). Unique Identifier : AIDSLINE MED/93333240
Goulet V; Broudic I; Pinget R; Meyer L; Reseau National de Sante Publique, Hosp. St Maurice, France.

Abstract: A study was performed among a national sample of 1/7 of the 4193 microbiological French laboratories. They were asked how many gonococcal infections they have diagnosed during the year 1991. The response rate among the 599 which were sampled was 88%. A mean of 1.82 [1.51-2.13] male gonococcal isolates was declared. For France, the incidence of microbiological ascertained gonorrhoea in 1991 is thus 7,631 [6,331-8,931]. This estimate concerns microbiologically diagnosed infections. The true incidence of gonococcal infections is thus higher, as all the infections are not microbiologically ascertained in private practice. The proportion of male gonorrhoea cases that are treated without microbiological confirmation was estimated to be 70% in two French studies (J Epid Comm Health. 1991; 45:152-58). If we use this figure, we can consider that 10879 male gonorrhea cases occurred in France outside STD clinics. In France there are about 300 STD clinics that diagnosed 1933 male infections in 1990. We can add the 1933 male infections diagnosed in these clinics to the 10,901 estimated, giving a total number of 12,834 male gonorrhoea cases, i.e. an incidence rate of 74/100,000 inhabitants (15-59 years). This rate is very similar to the one observed in England and Wales.
Keywords: *Gonorrhea/EPIDEMIOLOGYKWDgonorrhea/epidemiology
931130
M93B5809

Copyright © 1993 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1993. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1993. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .